North Americans were also more likely to initiate anti-TNF therapy as early preventive therapy after an ileal resection for internal penetrating disease (median 80% (IQR 40-100%) vs. 50% (IQR 0-100%) in both Europe and elsewhere, p=0.011). Here, TNF is linked to glycogen storage disease VI.